Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are receptor studies useful for clinical practice?

E Richelson

    The Journal of Clinical Psychiatry
    |September 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    This study evaluates the clinical value of receptor binding data for psychotropic drugs, focusing on antidepressants. It presents antidepressant affinities for human brain neurotransmitter receptors and related pharmacologic information.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurotensin agonists in the regulation of food intake.

    International journal of obesity (2005)·2013
    Same author

    Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.

    European journal of pain (London, England)·2012
    Same author

    NT69L, a novel analgesic, shows synergy with morphine.

    Brain research·2009
    Same author

    Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.

    Pharmacology, biochemistry, and behavior·2005
    Same author

    Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.

    Psychopharmacology·2004
    Same author

    The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.

    Behavioural brain research·2003

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Psychiatry

    Background:

    • Receptor binding studies are crucial for understanding drug mechanisms.
    • Antidepressants exert their effects through interactions with various neurotransmitter systems.
    • Assessing the clinical utility of these binding data is essential for drug development and application.

    Purpose of the Study:

    • To examine the validity and clinical usefulness of receptor binding studies for psychotropic medications.
    • To specifically evaluate the role of such studies in understanding antidepressant action.
    • To correlate receptor binding affinities with other pharmacologic properties of antidepressants.

    Main Methods:

    • Review of existing literature on psychotropic drug receptor binding.

    Related Experiment Videos

  • Compilation of data on antidepressant affinities for human brain receptors.
  • Analysis of pharmacologic data alongside receptor binding information.

    • Main Results:

    • Antidepressants exhibit varying affinities for diverse neurotransmitter receptors in the human brain.
    • Receptor binding data provides a framework for understanding the pharmacologic profiles of antidepressants.
    • The presented data highlights the complexity of drug-receptor interactions.

    Conclusions:

    • Receptor binding studies offer valuable insights into the mechanisms of antidepressant action.
    • The clinical usefulness of these studies is supported by their ability to explain drug effects.
    • Further research can leverage this data for more targeted psychotropic drug development.